SlideShare a Scribd company logo
Group Activity-Protein and fat recommendation for type 2 diabetes

Newly diagnosed type-2 diabetes requires alter previous patterns of eating and implementing new
eating behaviours and adherence to meal planning principles to learn specific nutrition
recommendations. Next to carbohydrate the amount of protein and fat in meal planning according
to individual need having a significant importance to maintain good metabolic control, wt.
management as well as prevention long term complications of diabetes such as nephropathy,
hypertension and cardiovascular diseases.

ADA recommendations for protein in type-2 diabetes

    •   Individual with type-2 diabetes and normal renal function the usual protein intake should be
        15-20% of energy. (1,2)

    •   Protein ingested by individual with type 2 diabetes can increase insulin response without
        increasing plasma glucose concentrations. Therefore, protein should not be used to treat
        acute or prevent night time hyperglycaemia.(1,2)

    •   As a method of weight loss high protein diets are not recommended as they may produce
        short term weight loss and improved glycaemia. The long term effects of protein intake >
        20%, of calories on diabetes management and its complications such as nephropathy are still
        not been established.(1,2)

Recent research in type-2 diabetes patients have shown that chronologically scheduled snacking
with high protein products within the habitual diet leads to loss of fat mass (4).
Table 1 Changes in biochemical determinations between the beginning and the end of the study. Baseline
Final p
Glucose (mg/dL)                                               159.2 ± 62.2 156.7 ± 59.4 ns
Insulin (mU/L)                                               10.2 ± 5.1 10.0 ± 4.9 ns
HOMA-IR                                                       3.65 ± 2.00 3.43 ± 1.84 ns
Glycosylated He m o globin (%)                               7.0 ± 1.3 7.2 ± 1.5 ns
Total cholesterol (mg/dL)                                    177.0 ± 37.4 176.9 ± 32.8 ns
HDL- cholesterol (mg/dL)                                     42.7 ± 9.0 42.5 ± 8.1 ns
LDL- cholesterol (mg/dL)                                     92.0 ± 37.2 102.9 ± 25.7 ns
Tryglycerides (mg/dL)                                        178.5 ± 103.6 157.7 ± 92.8 ns
AST (UI/L)                                                   31.8 ± 22.2 26.9 ± 16. 1 ns
ALT (UI/L)                                                   36.6 ± 23.5 31.6 ± 19.5 ns
Uric acid (mg/dL)                                           5.8 ± 1.3 6.1 ± 1.5 ns
Ho m ocysteineμmol/L)
               (                                          22.7 ± 4.4 23.3 ± 4.4 ns
C-reactive protein (mg/L)                                   13.6 ± 15. 1 9.8 ± 10.7 ns

A small change in habitual dietary recommendations by include of specific low glycaemia,
moderately high protein product in breakfast and morning and afternoon snacks can promote body
weight and fat mass loss without significant changes in biochemical parameters and cardio vascular
risk factors. Also important for regulating meal frequency and timing, (4)

Dietary fat and cholesterol

ADA recommendations for people with type 2 diabetes

    •   Saturated for should be > 7% of total calories. (1,2)
•   Intake of trans fat should be minimised. (1,2)

•   Individual with diabetes should limit dietary cholesterol to < 200 mg / day (1,2)

•   Two or more servings of fish / week (expert commercially fried fish filets) provide n -3
    polyunsaturated fatty acids (1,2)

The primary goal for above recommendations is to reduce risk of CVD as saturated and trans
fatty acids are the major determinants of plasma LDL cholesterol.

Diet high in polyunsaturated fatty acid or mono unsaturated fatty acid appears to have similar
effect on plasma lipid concentration. In a study motility rate reduce by 7% in elderly Europeans
who took Mediterranean diet where poly unsaturated FA were substitute for monounsaturated
fatty acids, (1)

References:

    1. American Diabetes Association: Nutrition Recommendations and interventions for
       Diabetes (Position Statement); Diabetes Care, Vol 31, Supp-1,S 61-S 74,2008.

    2. Monika Toeller: Lifestyle Issues: Diet; Text book of Diabetes; Chapter-22,4th edition.

    3. Madelyn L.Wheeler et al; Macronutrient, food groups and eating patterns in the
       management of Diabetes (A systemic literature review, 2010); Diabetes Care-35, S 434-
       S445, February 2012.

    4. Santiago Navas-Carretero et al; Chronogically scheduled snacking with high-protein
       products within the habitual diet in type 2 diabetes leads to a fat mass loss; A
       longitudinal study: Nutrition Journal 2011,10:74

    5. Natalie D.Luscombe-Marsh et al;Carbohydrate restricted diets high in either monoun-
       saturated fat or protein are equally effective at promoting fat loss and improving blood
       lipids; Am J Clin Nutr 2005;81: S 762-S 772.

More Related Content

What's hot

Low carb diet in diabetes, 2 year results
Low carb diet in diabetes, 2 year resultsLow carb diet in diabetes, 2 year results
Low carb diet in diabetes, 2 year results
Reijo Laatikainen
 
Metformin
MetforminMetformin
Metformin
Maduka Sanjeewa
 
Glycaemic Index- A key Factor in Diabetes Management
Glycaemic Index- A key Factor in Diabetes ManagementGlycaemic Index- A key Factor in Diabetes Management
Glycaemic Index- A key Factor in Diabetes Management
nutritionistrepublic
 
GLP-1 Agonist
GLP-1 AgonistGLP-1 Agonist
GLP-1 Agonist
Linh Huynh, PharmD
 
Glp1 clinical view
Glp1 clinical viewGlp1 clinical view
Glp1 clinical view
Dr. Adel El Naggar
 
Ueda2016 symposium - metformin ® xr - mohamed mashaheet
Ueda2016 symposium - metformin ® xr - mohamed mashaheetUeda2016 symposium - metformin ® xr - mohamed mashaheet
Ueda2016 symposium - metformin ® xr - mohamed mashaheet
ueda2015
 
Glycemic Index
Glycemic IndexGlycemic Index
Glycemic Index
Ratbag Media
 
Metformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drugMetformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drug
purebusiness
 
Intermittent fasting and Autophagy
Intermittent fasting and AutophagyIntermittent fasting and Autophagy
Intermittent fasting and Autophagy
sudharani028
 
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanem
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanemUeda2016 symposium - glp-1 story,a closer look -yehia ghanem
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanem
ueda2015
 
Role of metformin in dm2 &amp; glibenclamide combination
Role of metformin in dm2 &amp; glibenclamide combinationRole of metformin in dm2 &amp; glibenclamide combination
Role of metformin in dm2 &amp; glibenclamide combination
Dr. Adel El Naggar
 
Med Basics: Metformin
Med Basics: MetforminMed Basics: Metformin
Med Basics: Metformin
MedSimple
 
Fats and inflammation
Fats and inflammationFats and inflammation
Fats and inflammation
Reijo Laatikainen
 
MidAtlantic Poster
MidAtlantic PosterMidAtlantic Poster
MidAtlantic Poster
Suzanne Bowser
 
Doctoral Degree in Psychology, Health and Statistical Science
Doctoral Degree in Psychology, Health and Statistical Science Doctoral Degree in Psychology, Health and Statistical Science
Doctoral Degree in Psychology, Health and Statistical Science
Krizia Ferrini
 
Glycemic Index
Glycemic Index Glycemic Index
Glycemic Index
nutritionistrepublic
 
H032046050
H032046050H032046050
H032046050
inventionjournals
 
Metformin
MetforminMetformin
Metformin
drtvnrao
 
Sydney diet heart
Sydney diet heart Sydney diet heart
Sydney diet heart
Reijo Laatikainen
 
Butter is not a good choice for low carber
Butter is not a good choice for low carberButter is not a good choice for low carber
Butter is not a good choice for low carber
Reijo Laatikainen
 

What's hot (20)

Low carb diet in diabetes, 2 year results
Low carb diet in diabetes, 2 year resultsLow carb diet in diabetes, 2 year results
Low carb diet in diabetes, 2 year results
 
Metformin
MetforminMetformin
Metformin
 
Glycaemic Index- A key Factor in Diabetes Management
Glycaemic Index- A key Factor in Diabetes ManagementGlycaemic Index- A key Factor in Diabetes Management
Glycaemic Index- A key Factor in Diabetes Management
 
GLP-1 Agonist
GLP-1 AgonistGLP-1 Agonist
GLP-1 Agonist
 
Glp1 clinical view
Glp1 clinical viewGlp1 clinical view
Glp1 clinical view
 
Ueda2016 symposium - metformin ® xr - mohamed mashaheet
Ueda2016 symposium - metformin ® xr - mohamed mashaheetUeda2016 symposium - metformin ® xr - mohamed mashaheet
Ueda2016 symposium - metformin ® xr - mohamed mashaheet
 
Glycemic Index
Glycemic IndexGlycemic Index
Glycemic Index
 
Metformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drugMetformin is a revolutionary anti diabetic drug
Metformin is a revolutionary anti diabetic drug
 
Intermittent fasting and Autophagy
Intermittent fasting and AutophagyIntermittent fasting and Autophagy
Intermittent fasting and Autophagy
 
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanem
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanemUeda2016 symposium - glp-1 story,a closer look -yehia ghanem
Ueda2016 symposium - glp-1 story,a closer look -yehia ghanem
 
Role of metformin in dm2 &amp; glibenclamide combination
Role of metformin in dm2 &amp; glibenclamide combinationRole of metformin in dm2 &amp; glibenclamide combination
Role of metformin in dm2 &amp; glibenclamide combination
 
Med Basics: Metformin
Med Basics: MetforminMed Basics: Metformin
Med Basics: Metformin
 
Fats and inflammation
Fats and inflammationFats and inflammation
Fats and inflammation
 
MidAtlantic Poster
MidAtlantic PosterMidAtlantic Poster
MidAtlantic Poster
 
Doctoral Degree in Psychology, Health and Statistical Science
Doctoral Degree in Psychology, Health and Statistical Science Doctoral Degree in Psychology, Health and Statistical Science
Doctoral Degree in Psychology, Health and Statistical Science
 
Glycemic Index
Glycemic Index Glycemic Index
Glycemic Index
 
H032046050
H032046050H032046050
H032046050
 
Metformin
MetforminMetformin
Metformin
 
Sydney diet heart
Sydney diet heart Sydney diet heart
Sydney diet heart
 
Butter is not a good choice for low carber
Butter is not a good choice for low carberButter is not a good choice for low carber
Butter is not a good choice for low carber
 

Similar to Group activity-module-2

MNT_in_Diabetes_and_Related_Disorders.ppt
MNT_in_Diabetes_and_Related_Disorders.pptMNT_in_Diabetes_and_Related_Disorders.ppt
MNT_in_Diabetes_and_Related_Disorders.ppt
DrirFaisalHasan
 
GENETIC DIET- Maria vranceanu dubai nutrition conference
GENETIC DIET- Maria vranceanu  dubai nutrition conferenceGENETIC DIET- Maria vranceanu  dubai nutrition conference
GENETIC DIET- Maria vranceanu dubai nutrition conference
MARIA VRANCEANU
 
ASPIRUS metabolic parameters#1
ASPIRUS metabolic parameters#1ASPIRUS metabolic parameters#1
ASPIRUS metabolic parameters#1
Jonathan Russell
 
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHYDIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY
Paa Kwesi Hackman
 
Diabesity (Diabetes and Obesity)
Diabesity (Diabetes and Obesity)Diabesity (Diabetes and Obesity)
Diabesity (Diabetes and Obesity)
simplyweight
 
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumers
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumersAapi geeta sikand 6-29-12-final- heart-health-talk-consumers
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumers
AAPIconvention
 
Basal-Insulin-CME_Slides (2).pptx
Basal-Insulin-CME_Slides (2).pptxBasal-Insulin-CME_Slides (2).pptx
Basal-Insulin-CME_Slides (2).pptx
ssuser8c7e351
 
GLP+BASAL INSULIN COMBINATION.pptx
GLP+BASAL INSULIN COMBINATION.pptxGLP+BASAL INSULIN COMBINATION.pptx
GLP+BASAL INSULIN COMBINATION.pptx
Sher Zaman
 
Enrich Programme
Enrich ProgrammeEnrich Programme
Diabetes mellitus-treatment and psychiatric effects
Diabetes mellitus-treatment and psychiatric effectsDiabetes mellitus-treatment and psychiatric effects
Diabetes mellitus-treatment and psychiatric effects
Megha Isac
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
dibufolio
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
ueda2015
 
ueda2012 cgc 2-d.adel
ueda2012 cgc 2-d.adelueda2012 cgc 2-d.adel
ueda2012 cgc 2-d.adel
ueda2015
 
Continuous Care Intervention in Type 2 Diabetes
Continuous Care Intervention in Type 2 DiabetesContinuous Care Intervention in Type 2 Diabetes
Continuous Care Intervention in Type 2 Diabetes
James McCarter
 
the advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose controlthe advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose control
januar arifin
 
Management of diabetes mellitus.pptx me
Management  of diabetes mellitus.pptx meManagement  of diabetes mellitus.pptx me
Management of diabetes mellitus.pptx me
Hasan Ibna Kamal MCIPS
 
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan LifestyleReversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
Jen King
 
Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?
philaberry
 
Saxagliptin Diabetes DPP4 evidences & Trials
Saxagliptin Diabetes DPP4 evidences & TrialsSaxagliptin Diabetes DPP4 evidences & Trials
Saxagliptin Diabetes DPP4 evidences & Trials
AmitSaha472186
 
QR_T2DM_6th_Edition_QR_Guide_Digital.pdf
QR_T2DM_6th_Edition_QR_Guide_Digital.pdfQR_T2DM_6th_Edition_QR_Guide_Digital.pdf
QR_T2DM_6th_Edition_QR_Guide_Digital.pdf
BekiUje
 

Similar to Group activity-module-2 (20)

MNT_in_Diabetes_and_Related_Disorders.ppt
MNT_in_Diabetes_and_Related_Disorders.pptMNT_in_Diabetes_and_Related_Disorders.ppt
MNT_in_Diabetes_and_Related_Disorders.ppt
 
GENETIC DIET- Maria vranceanu dubai nutrition conference
GENETIC DIET- Maria vranceanu  dubai nutrition conferenceGENETIC DIET- Maria vranceanu  dubai nutrition conference
GENETIC DIET- Maria vranceanu dubai nutrition conference
 
ASPIRUS metabolic parameters#1
ASPIRUS metabolic parameters#1ASPIRUS metabolic parameters#1
ASPIRUS metabolic parameters#1
 
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHYDIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY
 
Diabesity (Diabetes and Obesity)
Diabesity (Diabetes and Obesity)Diabesity (Diabetes and Obesity)
Diabesity (Diabetes and Obesity)
 
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumers
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumersAapi geeta sikand 6-29-12-final- heart-health-talk-consumers
Aapi geeta sikand 6-29-12-final- heart-health-talk-consumers
 
Basal-Insulin-CME_Slides (2).pptx
Basal-Insulin-CME_Slides (2).pptxBasal-Insulin-CME_Slides (2).pptx
Basal-Insulin-CME_Slides (2).pptx
 
GLP+BASAL INSULIN COMBINATION.pptx
GLP+BASAL INSULIN COMBINATION.pptxGLP+BASAL INSULIN COMBINATION.pptx
GLP+BASAL INSULIN COMBINATION.pptx
 
Enrich Programme
Enrich ProgrammeEnrich Programme
Enrich Programme
 
Diabetes mellitus-treatment and psychiatric effects
Diabetes mellitus-treatment and psychiatric effectsDiabetes mellitus-treatment and psychiatric effects
Diabetes mellitus-treatment and psychiatric effects
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
 
ueda2012 cgc 2-d.adel
ueda2012 cgc 2-d.adelueda2012 cgc 2-d.adel
ueda2012 cgc 2-d.adel
 
Continuous Care Intervention in Type 2 Diabetes
Continuous Care Intervention in Type 2 DiabetesContinuous Care Intervention in Type 2 Diabetes
Continuous Care Intervention in Type 2 Diabetes
 
the advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose controlthe advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose control
 
Management of diabetes mellitus.pptx me
Management  of diabetes mellitus.pptx meManagement  of diabetes mellitus.pptx me
Management of diabetes mellitus.pptx me
 
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan LifestyleReversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
Reversing Diabetes Naturally Therapeutic Effects Of A Vegan Lifestyle
 
Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?
 
Saxagliptin Diabetes DPP4 evidences & Trials
Saxagliptin Diabetes DPP4 evidences & TrialsSaxagliptin Diabetes DPP4 evidences & Trials
Saxagliptin Diabetes DPP4 evidences & Trials
 
QR_T2DM_6th_Edition_QR_Guide_Digital.pdf
QR_T2DM_6th_Edition_QR_Guide_Digital.pdfQR_T2DM_6th_Edition_QR_Guide_Digital.pdf
QR_T2DM_6th_Edition_QR_Guide_Digital.pdf
 

Group activity-module-2

  • 1. Group Activity-Protein and fat recommendation for type 2 diabetes Newly diagnosed type-2 diabetes requires alter previous patterns of eating and implementing new eating behaviours and adherence to meal planning principles to learn specific nutrition recommendations. Next to carbohydrate the amount of protein and fat in meal planning according to individual need having a significant importance to maintain good metabolic control, wt. management as well as prevention long term complications of diabetes such as nephropathy, hypertension and cardiovascular diseases. ADA recommendations for protein in type-2 diabetes • Individual with type-2 diabetes and normal renal function the usual protein intake should be 15-20% of energy. (1,2) • Protein ingested by individual with type 2 diabetes can increase insulin response without increasing plasma glucose concentrations. Therefore, protein should not be used to treat acute or prevent night time hyperglycaemia.(1,2) • As a method of weight loss high protein diets are not recommended as they may produce short term weight loss and improved glycaemia. The long term effects of protein intake > 20%, of calories on diabetes management and its complications such as nephropathy are still not been established.(1,2) Recent research in type-2 diabetes patients have shown that chronologically scheduled snacking with high protein products within the habitual diet leads to loss of fat mass (4). Table 1 Changes in biochemical determinations between the beginning and the end of the study. Baseline Final p Glucose (mg/dL) 159.2 ± 62.2 156.7 ± 59.4 ns Insulin (mU/L) 10.2 ± 5.1 10.0 ± 4.9 ns HOMA-IR 3.65 ± 2.00 3.43 ± 1.84 ns Glycosylated He m o globin (%) 7.0 ± 1.3 7.2 ± 1.5 ns Total cholesterol (mg/dL) 177.0 ± 37.4 176.9 ± 32.8 ns HDL- cholesterol (mg/dL) 42.7 ± 9.0 42.5 ± 8.1 ns LDL- cholesterol (mg/dL) 92.0 ± 37.2 102.9 ± 25.7 ns Tryglycerides (mg/dL) 178.5 ± 103.6 157.7 ± 92.8 ns AST (UI/L) 31.8 ± 22.2 26.9 ± 16. 1 ns ALT (UI/L) 36.6 ± 23.5 31.6 ± 19.5 ns Uric acid (mg/dL) 5.8 ± 1.3 6.1 ± 1.5 ns Ho m ocysteineμmol/L) ( 22.7 ± 4.4 23.3 ± 4.4 ns C-reactive protein (mg/L) 13.6 ± 15. 1 9.8 ± 10.7 ns A small change in habitual dietary recommendations by include of specific low glycaemia, moderately high protein product in breakfast and morning and afternoon snacks can promote body weight and fat mass loss without significant changes in biochemical parameters and cardio vascular risk factors. Also important for regulating meal frequency and timing, (4) Dietary fat and cholesterol ADA recommendations for people with type 2 diabetes • Saturated for should be > 7% of total calories. (1,2)
  • 2. Intake of trans fat should be minimised. (1,2) • Individual with diabetes should limit dietary cholesterol to < 200 mg / day (1,2) • Two or more servings of fish / week (expert commercially fried fish filets) provide n -3 polyunsaturated fatty acids (1,2) The primary goal for above recommendations is to reduce risk of CVD as saturated and trans fatty acids are the major determinants of plasma LDL cholesterol. Diet high in polyunsaturated fatty acid or mono unsaturated fatty acid appears to have similar effect on plasma lipid concentration. In a study motility rate reduce by 7% in elderly Europeans who took Mediterranean diet where poly unsaturated FA were substitute for monounsaturated fatty acids, (1) References: 1. American Diabetes Association: Nutrition Recommendations and interventions for Diabetes (Position Statement); Diabetes Care, Vol 31, Supp-1,S 61-S 74,2008. 2. Monika Toeller: Lifestyle Issues: Diet; Text book of Diabetes; Chapter-22,4th edition. 3. Madelyn L.Wheeler et al; Macronutrient, food groups and eating patterns in the management of Diabetes (A systemic literature review, 2010); Diabetes Care-35, S 434- S445, February 2012. 4. Santiago Navas-Carretero et al; Chronogically scheduled snacking with high-protein products within the habitual diet in type 2 diabetes leads to a fat mass loss; A longitudinal study: Nutrition Journal 2011,10:74 5. Natalie D.Luscombe-Marsh et al;Carbohydrate restricted diets high in either monoun- saturated fat or protein are equally effective at promoting fat loss and improving blood lipids; Am J Clin Nutr 2005;81: S 762-S 772.